5-[(3-bromophenyl)carbamoylamino]-2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-(2-morpholin-4-ylethyl)benzamide

C31H37BrN6O4 — CID 42660036

IUPAC5-[(3-bromophenyl)carbamoylamino]-2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-(2-morpholin-4-ylethyl)benzamide
SMILESCOc1ccccc1N1CCN(c2ccc(NC(=O)Nc3cccc(Br)c3)cc2C(=O)NCCN2CCOCC2)CC1
InChIInChI=1S/C31H37BrN6O4/c1-41-29-8-3-2-7-28(29)38-15-13-37(14-16-38)27-10-9-25(35-31(40)34-24-6-4-5-23(32)21-24)22-26(27)30(39)33-11-12-36-17-19-42-20-18-36/h2-10,21-22H,11-20H2,1H3,(H,33,39)(H2,34,35,40)
InChIKeyFHDPMGHUMGBYEK-UHFFFAOYSA-N
MW637.58 g/mol
LogP4.49
Rot. Bonds9

About 5-[(3-bromophenyl)carbamoylamino]-2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-(2-morpholin-4-ylethyl)benzamide

5-[(3-bromophenyl)carbamoylamino]-2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-(2-morpholin-4-ylethyl)benzamide (PubChem CID 42660036) has the molecular formula C31H37BrN6O4 and a molecular weight of 637.58 g/mol. Its IUPAC name is 5-[(3-bromophenyl)carbamoylamino]-2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-(2-morpholin-4-ylethyl)benzamide.

Molecular Properties

Compound Name5-[(3-bromophenyl)carbamoylamino]-2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-(2-morpholin-4-ylethyl)benzamide
PubChem CID42660036
Molecular FormulaC31H37BrN6O4
Molecular Weight637.58 g/mol
Exact Mass636.21
IUPAC Name5-[(3-bromophenyl)carbamoylamino]-2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-(2-morpholin-4-ylethyl)benzamide
SMILESCOc1ccccc1N1CCN(c2ccc(NC(=O)Nc3cccc(Br)c3)cc2C(=O)NCCN2CCOCC2)CC1
InChIInChI=1S/C31H37BrN6O4/c1-41-29-8-3-2-7-28(29)38-15-13-37(14-16-38)27-10-9-25(35-31(40)34-24-6-4-5-23(32)21-24)22-26(27)30(39)33-11-12-36-17-19-42-20-18-36/h2-10,21-22H,11-20H2,1H3,(H,33,39)(H2,34,35,40)
InChIKeyFHDPMGHUMGBYEK-UHFFFAOYSA-N
XLogP4.49
TPSA98.41 Ų
H-Bond Donors3
H-Bond Acceptors7
Rotatable Bonds9
Heavy Atoms42
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500637.58
LogP ≤ 54.49
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'}

Analyze 5-[(3-bromophenyl)carbamoylamino]-2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-(2-morpholin-4-ylethyl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-[(3-bromophenyl)carbamoylamino]-2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-(2-morpholin-4-ylethyl)benzamide?
The IUPAC name of 5-[(3-bromophenyl)carbamoylamino]-2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-(2-morpholin-4-ylethyl)benzamide (CID 42660036) is 5-[(3-bromophenyl)carbamoylamino]-2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-(2-morpholin-4-ylethyl)benzamide.
What is the SMILES notation for 5-[(3-bromophenyl)carbamoylamino]-2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-(2-morpholin-4-ylethyl)benzamide?
The canonical SMILES for 5-[(3-bromophenyl)carbamoylamino]-2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-(2-morpholin-4-ylethyl)benzamide is COc1ccccc1N1CCN(c2ccc(NC(=O)Nc3cccc(Br)c3)cc2C(=O)NCCN2CCOCC2)CC1.
What is the InChIKey of 5-[(3-bromophenyl)carbamoylamino]-2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-(2-morpholin-4-ylethyl)benzamide?
The InChIKey is FHDPMGHUMGBYEK-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H37BrN6O4/c1-41-29-8-3-2-7-28(29)38-15-13-37(14-16-38)27-10-9-25(35-31(40)34-24-6-4-5-23(32)21-24)22-26(27)30(39)33-11-12-36-17-19-42-20-18-36/h2-10,21-22H,11-20H2,1H3,(H,33,39)(H2,34,35,40).
What are the key properties of 5-[(3-bromophenyl)carbamoylamino]-2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-(2-morpholin-4-ylethyl)benzamide?
5-[(3-bromophenyl)carbamoylamino]-2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-(2-morpholin-4-ylethyl)benzamide has a molecular weight of 637.58 g/mol, XLogP of 4.49, 9 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[(3-bromophenyl)carbamoylamino]-2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-(2-morpholin-4-ylethyl)benzamide is sourced from PubChem (CID 42660036), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).